Essentials of chronic kidney disease (CKD)
Chronic kidney disease is a significant worldwide problem.
- A nationally representative sample of 15,625 non-institutionalized adults aged 20 years and older from the NHANES III database suggested that the prevalence of CKD in the US adult population is 11% (19.2 million in the whole US population).1
- This equates to 5.9 million individuals (3.3%) with stage 1 CKD, and 7.6 million (4.3%) with stage 3.
Anaemia is a frequent comorbidity in patients with CKD with a prevalence of 48–68% in pre-dialysis patients. 2,3
- Severity and prevalence of anaemia increase alongside the decline in kidney function associated with CKD progression.
CKD, and anaemia in CKD patients, requires improved detection and classification using standardized criteria to improve outcomes.
1. Coresh J et al. Am J Kidney Dis 2003;41:1–12
2. McClellan W et al. Curr Med Res Opin 2004;20:1501–1510
3. Valderrabano F et al. Nephrol Dial Transplant 2003;18:89–100